Differing regulation of major histocompatibility; Class II and adhesion molecules on human umbilical vein endothelial cells by serotonin

International Archives of Allergy and Immunology

Volumn 112, Issue 2, 1997, Pages 145-151

  Li, Feng ^a   Joshua, Irving G ^a   Lian, Rebecca ^a   Justus, David E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

E selectin; Endothelial cells; Histamine; Intercellular adhesion molecules; Major histocompatibility class II; Serotonin

Indexed keywords

CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HISTAMINE; HLA ANTIGEN CLASS 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; MONOCLONAL ANTIBODY; SEROTONIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0031016451     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237446     Document Type: Article

References (29)

1. Arnaldi I, Reith W, Berte C, Mach B: Induction of HI, A class-II genes by IFN-y is transcriptional and requires a transacting protein, J Immunol 1989;142:999-1004.
2. Altmann DM, Hogg N, Trowsdale J, Wilkinson D: Cotransfection of ICAM-I and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells, Nature 1989:338:512-514.
3. Boyd AW, Wawryk SO, Burns GF, Fecondo JV: Intercellular adhesion molecule I (ICAM-I) has a central role in cell-cell contact-mediated immune mechanisms, Proc Natl Acad Sci USA 1988:85:395-399.
4. Natali PG, Scgatto D, Fcrrone S, Tosi R, Corte G: Different tissue distribution and ontogeny of DC-1 and HLA-DR antigens, Immunogcnctics 1984:19:109-116.
5. Pober JS, Gimbrone MA Jr., Cotran RS, Reiss CS, Burakoff SJ, Fiers W, Ault KA: la expression by vascular endothelium is inducible by activated T cells and by human y interferon, J Exp Med 1983;157:1339-1353.
6. Pober JS, Gimbrone MA, Lapierre LA, Men-drick DL, Fiers W Rothlein R, Springer TA: Overlapping patterns of activation of human endothelial cells by interleukin 1. tumor necrosis factor, and immune interferon, J Immunol 1986; 137:1893-1896.
7. Hellstrand K, Kylefjord H, Asea A, Hcrmods-son S: Regulation of the natural killer cell response to interferon-« by biogenic amines, J Interferon Res 1992; 12:199-206.
8. Sternberg EM, Wedncr JH, Leung MK, Parker C: Effects of serotonin and other monoamines on murine macrophages, J Immunol 1987:138: 4360-4365.
9. Sternberg EM, Trail J, Parker CW: Effect of serotonin on murine macrophages: Suppression of la expression by serotonin and its reversal by serotonin and its reversal by 5-1 If- serotonergic receptor antagonists, J Immunol 1986; 13:276-282.
10. Trinchieri G: Biology of natural killer cells, Adv Immunol 1989:47:187-376.
11. Bonnet M, Lespinats G, Burtin C: Histamine and serotonin suppression of lymphocyte response to phytohemagglutinin and antigen, Cell Immunol 1984;83:280-287.
12. Hirshbcrg H, Braathen LR, Thorsby E: Antigen presentation by vascular endothelial cells and epidermal Langerhans’ cells, Immunol Rev 1982:66:57-67.
13. Nunez G, Ball EJ, Stastmy P: Accessory cell function of human endothelial cells, J Immunol 1983;131:666-673.
14. Seppert TD, Lipsky PE: Antigen presentation by nterferon-y-treated endothelial cells and fibroblasts: Differential ability to function as antigen presenting cells despite comparable la expression, J Immunol 1985;135:3750-3762.
15. Glimcher LH, Kara CJ: Sequences and factors: A guide to MHC class-II transcription, Annu Rev Immunol 1992;10:13-49.
16. Shoskes DA, Wood KJ: Indirect presentation of MHC antigens in transplantation, Immunol Today 1994:15:32-38.
17. Hutchinson IV: Cellular mechanisms of allograft rejection, Curr Opin Immunol 1991:3: 722-728.
18. Lappin D, Whaley K: Effects of histamine on monocyte complement production, I, Inhibition of C2 production mediated by its action on Hi receptors, Clin Exp Immunol 1980:41:497-504.
19. Schwartz A, Askenase PW, Gershon RK: Histamine inhibition of the in vitro induction of cytotoxic T-cell responses, Immunopharmacology 1980;2:179-190.
20. Ihle JN, Kerr IM: Jaks and Stats in signaling by the cytokine receptor superfamily, Trends Genet 1995; 11:69-74.
21. Pelagrini S, Schindler C: Early events in signaling by interferons, Trends Biochem 1993:18: 338-342.
22. Müller M, Briscoe V, Lexton C, Guschin D, Zie-miccki A, Silvcnnoincn O, Harpur AG, Barbieri AG, Witthuhu BA, Schindler C, Pellegrini S, Wilks AF, Ihle JN, Stark GR, Kerr IM: The protein tyrosine kinase JAK I complements defects in interferon-«/ß and y signal transduction, Nature 1993;366:129-135.
23. Darnell JE Jr., Kerr IM, Starks GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins, Science 1994;264:1415-1421.
24. Shuai K, Schindler C, Presiozo VR, Darnell JE: Activation of transcription by IFN-y: Tyrosine phosphorylation of a 91 kDa DNA binding protein, Science 1992;258:1808-1812.
25. Shuai K, Stark GR, Kerr IM, Darnell JE: A single phosphotyrosine residue of stat 91 required for gene activation by interferon-y, Science 1993;261:1744-1746.
26. Fu XY: A direct signaling pathway through kinase activation of SH2 domain-containing transcription factors, J Leukoc Biol 1995:57:529-535.
27. Change CH, Fontes J, Peterlin M, Flavell A: Class-II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class-II genes, J Exp Med 1994; 180:1367-1374.
28. Decker T, Lew DJ, Mirkovitch J, Darnell JE: Cytoplasmic activation of GAF, an IFN-a-regu-latcd DNA-binding factor, EMBO J 1991; 10: 927-932.
29. Müller M, Laxton C, Briscoe J, Schindler C, Impiota T, Darnell JE, Starks GR, Kerr IM: Complementation of a mutant cell line: Central role of the 91 kDa polypeptide of 1SGF3 in the interferon-α and γ signal transduction pathways, EMBO J 1993;12:4221-4228.